Skip to main content

Table 2 Perioperative findings and clinical outcomes

From: Predictors of short-term thrombocytopenia after transcatheter aortic valve implantation: a retrospective study at a single Japanese center

  Total (n = 131) DPC of ≥ 50% (n = 74) DPC of < 50% (n = 57) P-value
Valve type (BEV) 110 (84%) 67 (90.5%) 43 (75.4%) 0.019
Contrast medium volume (mL) 86.7 ± 26.0 83.8 ± 18.9 90.5 ± 32.7 0.144
Operating time (min) 116.1 ± 45.5 113.6 ± 45.8 119.3 ± 45.3 0.479
Intraoperative blood loss (mL) 84.6 ± 11.5 90.2 ± 139 77.2 ± 73.9 0.526
PCPS 15 (11.5%) 8 (10.3%) 7 (12.3%) 0.793
(prophylactic/emergency) (13/2) (6/2) (7/0)  
Post-balloon dilation 39 (29.8%) 23 (31.1%) 16 (28.1%) 0.709
Intubation time of > 48 h 3 (2.3%) 2 (2.7%) 1 (1.8%) 0.730
Intensive care unit stay (days) 1.9 ± 4.6 1.6 ± 1.9 2.4 ± 6.7 0.328
Pacemaker implantation 10 (7.6%) 3 (4.1%) 7 (12.3%) 0.079
Atrial fibrillation 10 (7.6%) 5 (6.8%) 5 (8.8%) 0.667
Major stroke 2 (1.5%) 2 (2.7%) 0 (0%) 0.211
Acute kidney injury 3 (2.3%) 2 (2.7%) 1 (1.8%) 0.710
Tracheotomy 1 (0.7%) 0 (0%) 1 (1.8%) 0.253
Blood transfusions 64 (49%) 36 (48.7%) 28 (49%) 0.957
Infection 0 (0%) 0 (0%) 0 (0%)
Sepsis 0 (0%) 0 (0%) 0 (0%)
Death 0 (0%) 0 (0%) 0 (0%)
  1. DPC: decrease in platelet count; BEV: balloon-expandable valve; PCPS: percutaneous cardiopulmonary support
  2. Data are presented as mean ± standard deviation or n (%)